Table 2.

Characteristics of the study cohort are summarized as mean ± standard deviation and [minimum,maximum] of range or [percentage] values. Prognosis aortopathy patients had clinical follow-up data and were analyzed for growth rate validation of the aneurysm physiomarker; other patients did not have follow-up data. The p-values are reported for a Wilcoxon rank sum test between cohort statistics of healthy participants and all aortopathy patients.

	normal participants $(n=100)$	all aortopathy patients $(n=117)$	p-value	prognosis aortopathy patients $(n=72)$
age (years)	46.2±15.5 [19,79]	57.4±14.2 [22,86]	2 × 10−7	58.6±11.9 [29,79]
sex (female)	50 [50%]	35 [30%]	1.5 × 10−3	17 [24%]
height (m)	1.71±0.11 [1.30,1.96]	1.73±0.15 [1.14,2.03]	7.4 × 10−3	1.76±0.13 [1.40,2.03]
weight (kg)	79.2±17.9 [47.6,142.9]	84.8±18.1 [45.5,140.9]	3.5 × 10−2	86.5±19.2 [45.5,140.9]
follow-up (years)	-	-	-	5.86 ± 1.77 [1.13,8.67]